Position in EXEL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,809,659
-$113,958 QoQ
Shares Held
88,824
-0.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 97.6886877420517.ToString("F0")%
Shared 2.3113122579483023.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMERCE BANK holds $27,782,414 across 24 Biotechnology names. EXEL ranks #2 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,448 | $4,981,982 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
88,824 | $3,809,659 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,535 | $3,364,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,480 | $3,136,646 | |
| 5 | MRNA |
Moderna, Inc.
|
48,508 | $2,464,206 | |
| 6 | INCY |
Incyte Corp
|
19,518 | $1,837,033 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,131 | $1,783,685 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,860 | $1,154,291 |
All Filings in EXEL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,809,659 | 88,824 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,923,617 | 89,519 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,447,018 | 107,676 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,762,622 | 108,045 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $4,886,028 | 132,341 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $4,818,110 | 144,688 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,886,332 | 188,298 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,094,083 | 226,706 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,160,182 | 217,454 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,232,554 | 218,114 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,915,374 | 224,960 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,810,463 | 251,725 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,951,237 | 255,087 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,426,879 | 275,990 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,086,050 | 260,590 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $4,248,361 | 204,052 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,573,570 | 69,412 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,282,561 | 70,162 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,450,774 | 68,627 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,249,873 | 68,599 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,546,940 | 68,479 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,370,058 | 68,264 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,669,054 | 68,264 | Shares | Sole | 2020-11-06 | |
| No filing history on record for this holder in this stock. | ||||||